MARKET RESEARCH BRIEFING · 2024 –2030
Minimally Invasive Surgery Market Smaller incisions, larger opportunity — a USD 71.34 billion market by 2030, powered by chronic disease, ageing populations and surgical robotics.
Market size, 2023
Forecast, 2030
CAGR, 2024–2030
$44.90B
$71.34B
6.9%
Base year value
+$26.44B incremental value
North America leads share
Executive Summary Steady compounding: the market grows from USD 44.90B (2023) to USD 71.34B (2030) — a 59% uplift at a 6.9% CAGR. Structural demand: chronic disease and a growing geriatric population shift procedures toward less traumatic surgery. Technology premium: robotics, AI and AR navigation are the frontier — and the main battleground for leaders. Where to play: North America dominates today; Asia-Pacific shows a steady rise as infrastructure expands.
Copyright © Next Move Strategy Consulting
Source: NMSC Minimally Invasive Surgery Market Report · 01
01 · MARKET LANDSCAPE
A USD 71B Market by 2030, Built on on Less-Invasive Care Market Size & Growth (USD Billion) Base year 2023 · Forecast period 2024–2030 CAGR 2024–2030
$71.34B
6.9%
$44.90B
Absolute growth
+$26.44B Market share leader
North America 2023
2030
Key Insights Value story: MIS uses small incisions and a laparoscope to deliver less scarring, shorter stays, lower infection risk and faster recovery than open surgery. Regional share: North America holds the dominant share, backed by high chronic-disease burden and the presence of leaders such as Stryker and CONMED. Key restraint: high instrument cost raises treatment cost — a pricing lever for value-engineered and emerging-market offerings.
Industry Ecosystem — How the Market Is Segmented Service Type
Product Type
Technology
Laparoscopic surgery · Robotic
Surgical devices · Monitoring &
surgery
Monitoring & visualization · · Endo- & electrosurgical
Application
End-User
Cardiac · Cancer · Obesity · Cosmetic
Individual surgeons · Academic
Cosmetic
Academic & research
GI · Urology · Ortho & spine · Cardiac ·
Copyright © Next Move Strategy Consulting
Hospitals · Clinics · Individual
Transcatheter · Laparoscopy · NonNon-visual imaging · Medical
robotics
Coverage 4 regions · 28 countries · 20 · 20 companies profiled
Source: NMSC Minimally Invasive Surgery Market Report · 02
0 2 · G R O W T H D R I V E R S & O P P O R TU N I T I E S
Disease Burden and Ageing Turn Robotics into Volume 17.9M
9.3M
1.9M
28.9%
cardiovascular deaths
cancer deaths worldwide
new U.S. cancer cases
of Japan's population aged
(WHO, 2021)
(WHO, 2021)
(ACS, 2021)
aged 65+ (2021)
Growth Opportunity Map Europe Established market · 12
North America
country splits covered
Dominant share · key player presence (Stryker, CONMED)
Asia-Pacific Steady rise · China, India, Japan Japan infrastructure build-out out
RoW Latin America, Middle East, Africa Africa — emerging access
What Moves Demand
High-Growth Segments
Chronic disease: cardiovascular, cancer, respiratory and kidney disease expand the surgical caseload. Geriatric population: older patients need lower-trauma procedures with faster recovery.
Robotic surgery — precision & lower fatality risk Advanced laparoscopy — next-
Robotics & AI: e.g., Max Hospital's 2021 da Vinci Xi launch brings 3D-HD precision to routine care.
next-gen visualization
APAC upside: India's healthcare sector reached USD 372B in 2022 (NITI Aayog), funding advanced OR capacity.
heart (TAVI)
Transcatheter — structural
AR spine navigation — 3D screw screw placement
Copyright © Next Move Strategy Consulting
Source: NMSC report; WHO; ACS; Statistics Bureau of Japan · 03
03 · COMPETITIVE SCENARIO
Diversified Giants vs. Robotics Specialists Competitive Positioning Matrix Qualitative NMSC analyst view based on portfolio scope and recent robotic / digital launches
ROBOTICS SPECIALISTS
PLATFORM LEADERS
Robotics & digital-surgery intensity →
Intuitive Surgical
Medtronic
Zimmer Biomet
Johnson & Johnson
Stryker
Globus / NuVasive
Philips
Orthofix / SeaSpine
Abbott CONMED B. Braun Microline · Fortimedix NICHE / FOCUSED
Siemens Healthineers BROAD DEVICE PORTFOLIOS Breadth of MIS portfolio →
Positioning Insights Fragmented field: 20 profiled players span robotics, devices, imaging and spine — no single vendor covers every segment. Robotics race intensifies: Intuitive's da Vinci 5 (FDA, Mar 2024) now faces Medtronic Hugo (FDA, Dec 2025) and J&J OTTAVA (FDA de novo, Jul 2026). Product launches defend share: Abbott Navitor TAVI (Dec 2022), SeaSpine 7D FLASH spine module and Philips ClarifEye AR navigation (Oct 2022). Spine consolidation: Orthofix–SeaSpine and Globus–NuVasive mergers (2023) reshaped the MIS spine tier.
Copyright © Next Move Strategy Consulting
Source: NMSC report; company press releases; FDA · 04
04 · KEY STRATEGIES
M&A, Robotics Clearances and Market Market Expansion
$4.9B Stryker's Inari Medical deal (closed Feb 2025) — the
largest MIS-specific acquisition in this tracker
C om pany
D ate
Typ e
Strateg ic M ove
Stryker
Feb 2025
M& A
Inari M ed ical ($4.9B) — catheter- b ased VTE clo t rem oval
G lob us M ed ical
S ep 2023
M& A
C o m p leted m erg er with N uVasive — M IS sp ine scale
O rthofix
Jan 2023
M& A
M erg er o f eq uals with S eaS p ine (~ $693M TTM revenue)
B. Braun
S ep 2025
M& A
A cq uired True D ig ital S urg ery — ro b o tic 3D m icro sco py
Intuitive
M ar 2024
Launch
d a Vinci 5 FD A 510(k) clearance
M ed tronic
Jun 2026
Expansion
H ug o RA S 510(k) filing s fo r g eneral & g yneco lo g ic surg ery
J& J M ed Tech
Jul 2026
Launch
O TTAVA so ft- tissue ro b o t — FD A d e novo autho rizatio n
Philip s
2025
Partnership
Ind o nesia M o H — natio nwid e im ag e- g uid ed therapy ro llo ut
Implications for Investors & B2B Decision-Makers
Investors: M&A targets cluster in catheter-based, spine and digital-visualization assets — watch mid-cap innovators. Strategy teams: soft-tissue robotics is moving from monopoly to multi-vendor; pricing and service models will reset. B2B buyers: more robot platforms and emerging-market partnerships widen procurement choice and negotiating leverage.
Copyright © Next Move Strategy Consulting
Source: company press releases; SEC; FDA · 05
Thank You Connect with our analysts for in-depth MIS market insights, custom segment data and segment data and strategic guidance on your next move.
Click here for the complete report → Market share for 10 companies · 28 countries · free customization up to 80 analyst hours
WEBSITE
www.nextmsc.com
PHONE
+1 857 758 5017
info@nextmsc.com
Follow Us
Copyright © Next Move Strategy Consulting
YouTube
Twitter / X
06